Abattis Announces Acquisition of European Nutraceutical Company and Provides Corporate Updates
April 3, 2019 7:53 pmVANCOUVER, BRITISH COLUMBIA / January 17, 2019 / Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that the temporary order from the British Columbia Securities Commission (“BCSC”), issued on November 26, 2018 (the “Order”), has not been extended against Abattis.